Skip to main content
489 search results for:

Insulin Glulisine 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-04-2023 | Insulins | News

    Insulin-glargine/insulin-glulisine/zolpidem

    Sedation confusion and accidental exposure leading to hypoglycaemia factitia: case report
  2. 01-01-2023 | Insulin Glulisine | News

    Insulin-glulisine

    Hypoglycaemia and exogenous insulin antibody syndrome: case report
  3. 01-10-2022 | Insulin Glulisine | News

    Insulin glargine/insulin glulisine/olanzapine

    Hypoglycaemia, sedation and worsening of blood glucose control: case report
  4. 07-08-2022 | Insulin Glulisine | OriginalPaper

    A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes

    Diabetes is managed intensively with the use of continuous subcutaneous insulin infusion (CSII) and multiple daily insulin injections to achieve near-normal levels of blood glucose. The use of CSII is increasing in many European countries …

  5. Open Access 01-03-2021 | Insulin Glulisine | OriginalPaper

    Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study

    This article is published with digital features, including a summary slide, to facilitate understanding of the article. To view digital features for this article go to https://doi.org/10.6084/m9.figshare.13526510 .

  6. Open Access 01-03-2021 | Insulin Glulisine | OriginalPaper

    Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study

    This article is published with digital features, including a summary slide, to facilitate understanding of the article. To view digital features for this article go to https://doi.org/10.6084/m9.figshare.13526468 .

  7. 01-07-2021 | Insulin Glulisine | BriefCommunication

    Comparative effects of insulin glulisine and lispro on postprandial plasma glucose and lipid profile in Japanese patients with type 2 diabetes mellitus

    Cardiovascular diseases (CVD) is the most prevalent cause of mortality and morbidity in diabetic patients [ 1 , 2 ]. Previous studies in Asian patients with type 2 diabetes mellitus (T2DM) demonstrated that 2 h-plasma glucose (PG) concentration on …

  8. Open Access 01-02-2020 | Insulin Glulisine | OriginalPaper

    Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice

    The joint task force of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) updated its consensus on the management of type 2 diabetes (T2DM) in 2018 [ 1 ] reflecting both the epidemiologic and …

  9. 01-06-2021 | Cerebral Sinus Venous Thrombosis | News

    Insulin-glargine/insulin-glulisine

    Insulin resistance: case report
  10. 01-05-2019 | Insulin Glulisine | News

    Insulin glargine/insulin glulisine

    Drug specific antibodies and hypoglycaemia: case report
  11. 01-12-2018 | News

    Insulin aspart/insulin glulisine

    Subcutaneous lipoatrophy: case report
  12. 01-06-2018 | News

    Insulin-glargine/insulin-glulisine

    Lipoatrophy: case report
  13. 01-10-2017 | News

    Insulin glargine/insulin glulisine

    Recurrent hypoglycemia: case report
  14. 01-07-2017 | News

    Insulin-glargine/insulin-glulisine/insulin-lispro

    Type III hypersensitivity reaction: case report
  15. 01-01-2016 | News

    Insulin-aspart/insulin-detemir/insulin-glulisine

    Lipoatrophy: case report
  16. 01-05-2009 | OriginalPaper

    Insulin Glulisine

    A Review of its Use in the Management of Diabetes Mellitus

    The global number of individuals with diabetes mellitus was estimated at over 171 million in the year 2000 (a prevalence of 2.8%); this number is projected to rise to over 366 million (4.4%) by 2030, in part because of an aging population and an …

  17. 01-04-2006 | OriginalPaper

    Insulin Glulisine

    A Viewpoint by Mandana Ahmadian and William C. Duckworth
  18. 01-04-2006 | OriginalPaper

    Insulin Glulisine

    A Viewpoint by Jürgen Eckel
  19. 01-04-2006 | OriginalPaper

    Insulin Glulisine

    Insulin glulisine is a rapid-acting human insulin analogue that has a faster onset of action and shorter duration of action than regular human insulin (RHI) in patients with type 1 or 2 diabetes mellitus and is efficacious in controlling …

  20. 01-04-2006 | OriginalPaper

    Insulin Glulisine

    A Viewpoint by George Dailey

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.